Evolving Standards: An Examination of NAPLEX Blueprint Changes and Implications for the Academy
The 2025 NAPLEX blueprint resembles a shift toward clinical content in comparison to previous blueprints. Curricular outcomes related to solving problems; providing whole person care; and stewardship of medication systems for prescribing, order processing, dispensing, administration, and effects monitoring align with the new NAPLEX blueprint.
Authors
- Aleda M.H. Chen (ORCID: https://orcid.org/0000-0002-4636-8260)
- Diana M Sobieraj (ORCID: https://orcid.org/0000-0002-5227-0681)
- Lisa Lebovitz (ORCID: https://orcid.org/0000-0002-7720-0356)
- Sarah A. Spinler (ORCID: https://orcid.org/0000-0003-4552-0053)
- Thomas M. Ellington
- Mary E. Ray
- Michael P. Kelsch (ORCID: https://orcid.org/0000-0003-2903-1938)
Institutions
- Binghamton University (US)
- University of Iowa (US)
- University of Maryland, Baltimore (US)
- University of Connecticut (US)
- Cedarville University (US)
- Shenandoah University (US)
- North Dakota State University (US)
Publication Details
- Journal
- American Journal of Pharmaceutical Education
- Published
- 2025-04-04
- DOI
- https://doi.org/10.1016/j.ajpe.2025.101400
- Citations
- 4
- Primary Topic
- Innovations in Medical Education
- Type
- article
- Field-Weighted Citation Impact
- 7.51